Bosede Afolabi

Bosede Afolabi
Born
Bosede Bukola Afolabi

July 1970
NationalityNigerian
Alma materQueen’s College Yaba, Obafemi Awolowo University, University of Nottingham
Occupation(s)Consultant Obstetrician, Gynaecologist & Professor
Known forIVON Trial, SPEC-AI Study, Maternal health research
Websitebosedeafolabi.com

Professor Bosede Bukola Afolabi (born 1970) is a Nigerian obsotetrician, gynaecologist, maternal health researcher, and academic leader. She is a professor and head of the Department of Obstetrics and Gynaecology at the College of Medicine (CMUL), Lagos University Teaching Hospital (LUTH).[1][2][3] Bosede is the founder and chairperson of the Maternal and Reproductive Health Collective (MRHC), a research and training NGO.[4] She is also the Director at the Centre for Clinical Trials, Research and Implementation Science (CCTRIS).[5] Her research focuses on maternal anaemia, sickle cell disease in pregnancy, and high-risk obstetric care in sub-saharan Africa.[6][7][8][9][10]

Early life and education

Bosede was born in London in 1970 and pursued her secondary education at Queen’s College, Yaba.[11] She earned her MBChB from Obafemi Awolowo University, Ile-Ife, in 1992.[11][1] She proceeded to the University of Nottingham, U.K., where she was awarded a tuition scholarship to pursue a Doctor of Medicine (DM) degree part-time.[12] Her primary research entitled Plasma volume in normal and sickle cell pregnancies was accepted.[6][13] She earned a DM in Obstetrics and Gynaecology from the University of Nottingham in June 2011.[14][15]

She obtained postgraduate fellowships from:

  • Royal College of Obstetricians and Gynaecologists (FRCOG)[14][2]
  • West African College of Surgeons (FWACS)[14][11]
  • National Postgraduate Medical College of Nigeria (FMCOG) [14][11][16] 

She further enhanced her training with a Diploma in Medical Education from the Foundation for the Advancement of International Medical Education and Research (FAIMER), USA.[17] In 2016, she obtained a Certificate in Biostatistics and Epidemiology from the Harvard T.Chan School of Public Health in Boston, U.S.[14][18]

Career

Academic and clinical roles

Clinically, Bosede trained in the UK as a Senior House Officer (SHO) in Obstetrics and Gynaecology at Central Middlesex Hospital, London, and Hull Royal Infirmary, North Yorkshire, and SHO and Specialist Registrar in many UK Hospitals, before returning to Lagos, Nigeria in 1998.[11]

Bosede became a Senior Registrar for the Obstetrics and Gynecology Department at Lagos University Teaching Hospital in 2000 and later became a Consultant Obstetrician and Gynecologist in 2002, where she continues to serve until the present day.[1][7] In addition, she joined the College of Medicine at the University of Lagos as a Lecturer II; she progressed through several promotions until 2016 when she became a professor of Obstetrics and Gynaecology.[1][11] In 2018, she became the Head of the Department of Obstetrics and Gynaecology at the Lagos University Teaching Hospital (LUTH), a position she held until July 2021.[19] In August 2022, she was reappointed to this position.[2]

From October 2019 to June 2022, she served as the Assistant Editor of the Journal of the West African College of Surgeons.[11][1] In June 2022, she became the Editor in Chief and occupied the position until December 2022.[20] She is a PhD examiner of the Pan African University of Life and Earth Sciences, and has supervised 22 postgraduate thesis and is currently supervising 5 PHD students.[15][11] She has collaborated with various international academics, including researchers from the Universities of Nottingham and Greenwich, UK,[18][21] Institute of Tropical Medicine, Belgium, Karolinska Institute, Sweden,[22][10][23] London School of Hygiene and Tropical Medicine,[24][25] Harvard School of Public Health and Northeastern University USA.[18][11]

Leadership

She serves as:

  • Director, Centre for Clinical Trials, Research and Implementation Science (CCTRIS).[5][21]
  • Founder & Chairman, Maternal & Reproductive Health Collective (MRHC).[4]
  • Board member, Ekiti State University Teaching Hospital.[4][21][26]
  • Chairman, Kensington Adebukola Adebutu Foundation Laboratory & Maternity Centre.[26] 
  • President, Association of Fetomaternal Medicine Specialists of Nigeria (AFEMSON) since July 2023l[27]

Research

Bosede's research addresses anaemia, maternal medicine and safe delivery.[11][16] She has authored over 121 peer-reviewed publications.[11][16][24]

Major trials

  • IVON (Lancet Glob Health, Oct 2024): A multicenter randomized trial comparing intravenous ferric carboxymaltose vs. oral iron for antenatal anemia (1,056 women across Lagos and Kano) funded by the Bill & Melinda Gates Foundation.[28]
  • IVON-PP (BMJ Open, Aug 2024): A postpartum anemia implementation trial in Nigeria.[29]
  • IVON-IS: Assessing implementation strategies for IV iron (2022–25).[28]
  • CAPREMAN: Comprehensive approach to maternal anemia (2024–28).[30]
  • SPEC-AI: AI-based screening for peripartum cardiomyopathy, in partnership with Mayo Clinic.[31]

She is also co-investigator on Fogarty/NIH and TETFund-funded studies.[12]

Advocacy and public engagement

  • She was featured on CNN African Voices for her advocacy for women with sickle cell during pregnancy and her teaching, research, and clinical outcome in obstetrics and efforts to reduce maternal mortality.[32][33][34]
  • Her work has been featured on CNN, Arise TV, BBC, Daily Trust, The Punch, Medical World Nigeria, World Economic Forum, The Cable, The Guardian Nigerian News, Quartz Africa and so on.[35][36][37][38][39][40]
  • Featured speaker at the 2023 Gates Foundation Goalkeepers event, during the 78th United Nations General Assembly, highlighting rapid-acting IV iron solutions to save maternal lives.[41][42][43]

Honors and awards

  • In 2021, Bosede was awarded a Special Recognition Award by the Physician of the Year Award Committee for her commitment and dedication.[21][7]
  • Fellow: FRCOG, FWACS, FMCOG; Fellow of the Nigerian Academy of Medicine (FAMedS, 2021); Fellow of the Nigerian Academy of Science (FNAmed, 2023).[14]
  • Eisenhower Fellowship (2014).[44]
  • Excellence in Research, Society of Obstetricians & Gynaecologists of Nigeria (SOGON), 2022.[18][21]
  • Ojo Memorial Lecturer, SOGON's 56th Annual Scientific Conference, 2022.[45][11]

Selected publications

Bosede has authored over 121 peer-reviewed publications on various medical topics, many of which include Maternal medicine and Safe delivery.[11][16] Some of which includes:

  • Afolabi BB et al. (2024). Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON). Lancet Global Health.[28]
  • Afolabi BB et al. (2024). IVON-PP: Intravenous ferric carboxymaltose vs oral iron for postpartum anemia, BMJ Open.[29][46]
  • Afolabi BB et al. (2024). Acceptability of IV iron therapy in Nigeria, Reproductive Health.[47]
  • Afolabi BB (2011). Plasma volume in sickle cell pregnancies. DM Thesis, University of Nottingham.[6]

Grants and fellowships

Bosede's research focuses on improving maternal health.[16] She founded the Maternal and Reproductive Health Research Collective, a research and training NGO established to reduce the rate of pregnancy-related illness and death and improve the reproductive health of Nigerian women, through research, advocacy, and training programs.[4][48][34]

Her research and publications have focused on maternal mortality and sickle cell in pregnancy, anaemia, leading to multiple clinical trials and research collaborations.[6][8][49] She is a member of the Sickle Cell Foundation of Nigeria.[14]

These have formed the basis for various grants, fellowships, scholarships, and accolades from multiple bodies. Bosede is the principal investigator on a Bill and Melinda Gates Foundation grant for the IVON trial (Intravenous versus oral iron for iron deficiency anaemia in pregnant Nigerian women: a randomized controlled trial) as well as Country Principal Investigator on a grant for a study titled Preparedness and response to COVID-19: a global survey of maternal care providers - in-depth case study of large referral maternity wards in four countries in sub-Saharan Africa.[48][50][51]

Bosede is also the principal investigator for the PIPSICKLE Trial (Low dose aspirin for the prevention of intrauterine growth restriction and preeclampsia: a randomized controlled trial, (2020-2022) granted by TETFUND NRF.[52][53][46] She is also the Country Principal Investigator for a randomized controlled trial on screening of Peripartum Cardiomyopathies using Artificial Intelligence (SPEC -AI) in Nigeria (2022-2023).[54][31]

References

  1. ^ a b c d e "Bosede Afolabi". The Conversation. May 29, 2015. Retrieved June 20, 2025.
  2. ^ a b c "Bosede B Afolabi College of Medicine University of Lagos • Department of Obstetrics and Gynaecology". ResearchGate. Retrieved December 8, 2021.
  3. ^ "Professor Afolabi Delivers 4th Inaugural Lecture". unilag.edu.ng. May 6, 2019. Retrieved December 8, 2021.
  4. ^ a b c d "ABOUT US - MRHC". January 17, 2025. Retrieved June 20, 2025.
  5. ^ a b "Team - CCTRIS". CCTRIS -. April 27, 2023. Archived from the original on January 14, 2025. Retrieved June 20, 2025.
  6. ^ a b c d Afolabi, Bosede B; Oladipo, Olajumoke O; Akanmu, Alani S; Abudu, Olalekan O; Sofola, Olusoga A; Broughton Pipkin, Fiona (July 1, 2016). "Volume regulatory hormones and plasma volume in pregnant women with sickle cell disorder". Journal of the Renin-Angiotensin-Aldosterone System. 17 (3): 1470320316670444. doi:10.1177/1470320316670444. ISSN 1470-3203. PMC 5843859. PMID 27678389.
  7. ^ a b c "Advancing Women's Health and Wellbeing through High-Quality Research and Career Progression ~ Prof. Bosede Afolabi, HOD, Obstetrics and Gynaecology & Director, CCTRIS, University of Lagos". Medical Mirror. March 20, 2024. Retrieved June 20, 2025.
  8. ^ a b Alabi, Christiana T. (May 21, 2019). "Sickle cell: Don advocates policy on newborn screening". Daily Trust. Retrieved June 20, 2025.
  9. ^ "Improving Maternal Health In Nigeria, My Driving Force – Prof. Afolabi | Development Communications Network". www.devcomsnetwork.org. Retrieved June 20, 2025.
  10. ^ a b "Iron given to pregnant women intravenously is more effective than iron taken orally | Karolinska Institutet". news.ki.se. May 26, 2025. Retrieved June 20, 2025.
  11. ^ a b c d e f g h i j k l m "Bio – Bosede Afolabi". bosedeafolabi.com. Retrieved June 20, 2025.
  12. ^ a b "Sygen Pharma - Trusted Health Sciences Organization in Nigeria". Sygen Pharma. January 10, 2023. Retrieved June 20, 2025.
  13. ^ Afolabi, Bosede Bukola (June 2011). Plasma Volume in Normal and Sickle Cell Pregnancy (PDF) (Doctorate thesis). University of Nottingham.
  14. ^ a b c d e f g "Bosede Bukola Afolabi, MBCHB, DM (NOTTS), FRCOG, FWACS, FMCOG, DIP, MAS". onescdvoice.com. Retrieved December 8, 2021.
  15. ^ a b "Bosede Afolabi". LinkedIn.
  16. ^ a b c d e "My Bibliography | Bosede Afolabi's Bibliography". ncbi.nlm.nih.gov. Retrieved December 8, 2021.
  17. ^ Historical Nigeria Yoruba (December 3, 2024). "Bosede Bukola Afolabi: A Trailblazer in Maternal and Reproductive Health". Facebook. Retrieved June 22, 2025.
  18. ^ a b c d "Prof. Bosede Afolabi: Brilliant Mind, Healing Hands in Obstetrics". Dawn Commission. July 13, 2024. Retrieved June 20, 2025.
  19. ^ file:///Users/redwiremarketing/Downloads/Maternal%20Medicine%20Journeys%20of%20women%20in%20pregnancy,%20delivery%20and%20sickle%20cell%20disease%20(1).pdf
  20. ^ "Editorial Team". wajog.org.
  21. ^ a b c d e Ajumobi, Kemi (February 9, 2024). "Bosede Afolabi, Director, Clinical Trials, Research and Implementation Science (CCTRIS)". Businessday NG. Retrieved June 20, 2025.
  22. ^ https://unilag.edu.ng/?p=42048
  23. ^ "PhD defence Ochuwa Adiketu Babah". www.itg.be. May 15, 2025. Retrieved June 20, 2025.
  24. ^ a b "Bosede Bukola Afolabi". Scilit. Archived from the original on June 20, 2025. Retrieved June 26, 2025.
  25. ^ "Super proud to have been one of the contributors to this seminal work led by Dr Aduragbemi Banke-Thomas, an Associate Professor of Maternal and Newborn Health at the London School of Hygiene and… | Professor Bosede Afolabi". LinkedIn. 2024. Retrieved June 20, 2025.
  26. ^ a b "Bosede Afolabi". Business Day. February 9, 2024. Retrieved June 20, 2025 – via PressReader.
  27. ^ "About Us – AFEMSON". afemson.org. Retrieved June 20, 2025.
  28. ^ a b c Afolabi, Bosede B.; Babah, Ochuwa A.; Adeyemo, Titilope A.; Balogun, Mobolanle; Banke-Thomas, Aduragbemi; Abioye, Ajibola I.; Akinajo, Opeyemi R.; Galadanci, Hadiza S.; Quao, Rachel A.; Adelabu, Hameed; Sam-Agudu, Nadia A.; Adaramoye, Victoria O.; Abubakar, Abdulazeez; Banigbe, Bolanle; Olorunfemi, Gbenga (October 1, 2024). "Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial". The Lancet Global Health. 12 (10): e1649 – e1659. doi:10.1016/S2214-109X(24)00239-0. ISSN 2214-109X. PMC 11420468. PMID 39304237.
  29. ^ a b IVON-PP (BMJ Open, Aug 2024): A postpartum anemia implementation trial in Nigeria
  30. ^ "Newsletter - CCTRIS". cctris.org. Retrieved June 20, 2025.
  31. ^ a b Adedinsewo, Demilade A.; Onietan, Damilola; Morales-Lara, Andrea Carolina; Moideen Sheriff, Serin; Afolabi, Bosede B.; Kushimo, Oyewole A.; Mbakwem, Amam C.; Ibiyemi, Kehinde F.; Ogunmodede, James Ayodele; Raji, Hadijat Olaide; Ringim, Sadiq H.; Habib, Abdullahi A.; Hamza, Sabiu M.; Ogah, Okechukwu S.; Obajimi, Gbolahan (March 11, 2025). "Contextual challenges in implementing artificial intelligence for healthcare in low-resource environments: insights from the SPEC-AI Nigeria trial". Frontiers in Cardiovascular Medicine. 12. doi:10.3389/fcvm.2025.1516088. ISSN 2297-055X. PMC 11932990. PMID 40134980.
  32. ^ Duthiers, Vladimir (February 11, 2013). "Nigerian doctor fighting killer blood disease". CNN. Retrieved June 20, 2025.
  33. ^ Tutton, Mark (November 6, 2024). 2013: Dr. Bosede Afolabi explains why she chose medicine | CNN. Retrieved June 20, 2025 – via edition.cnn.com.
  34. ^ a b Tutton, Mark (January 16, 2025). 2013: Nigerian doctor helps pregnant women | CNN. Retrieved June 20, 2025 – via edition.cnn.com.
  35. ^ "ObGyn Prof Bose Afolabi of University of Lagos speaks on challenges of childbearing and motherhood". youtube.com. May 4, 2019. Retrieved December 8, 2021.
  36. ^ Afolabi: Why I chose medicine | CNN. February 1, 2013. Retrieved June 20, 2025 – via edition.cnn.com.
  37. ^ Doctor: Moving home wasn't 'fashionable' | CNN. February 1, 2013. Retrieved June 20, 2025 – via edition.cnn.com.
  38. ^ Arise News (May 4, 2019). ObGyn Prof Bose Afolabi of University of Lagos speaks on challenges of childbearing and motherhood (Video). Retrieved June 20, 2025 – via YouTube.
  39. ^ Ndukwe, Ijeoma (September 3, 2018). "In Nigeria, this baby kit bag is saving mother's life". BBC News. Retrieved December 8, 2021.
  40. ^ Gates, Bill (July 31, 2023). "For a bright future, invest in Africa's young". Daily Trust. Retrieved June 20, 2025.
  41. ^ Unit, UNILAG Communication (September 14, 2023). "Professor Bosede Afolabi to speak at 2023 GoalKeepers Event". University Of Lagos. Retrieved June 20, 2025.
  42. ^ 2023 Goalkeepers Report (PDF) (Report). 2023.
  43. ^ Bosede, Afolabi [@Coolgynae] (September 22, 2023). "I am deeply honored to have had the opportunity to discuss our research in pregnancy and childbirth at @cctris_, especially highlighting the potential of the groundbreaking single 15-minute intravenous (IV) iron infusion for treating anaemia in pregnancy" (Tweet) – via Twitter.
  44. ^ @EF_Fellows (January 24, 2022). "Professor of Obstetrics & Gynecology and Eisenhower Fellow, Bosede Afolabi (Nigeria '14) shares her successes, challenges and motivations #efjourney @Coolgynae https://leadership.ng/improving-maternal-health-in-nigeria-my-driving-force-prof-afolabi/" (Tweet) – via Twitter.
  45. ^ "Prof. Bosede Afolabi". www.mentorintroafrica.com. Retrieved June 20, 2025.
  46. ^ a b Afolabi, Bosede Bukola; Babah, Ochuwa Adiketu; Adeyemo, Titilope Adenike; Odukoya, Oluwakemi Ololade; Ezeaka, Chinyere Veronica; Nwaiwu, Obinyo; Oshodi, Yusuf Abisowo; Ogunnaike, Babatunde A (2021). "Low-dose aspirin for preventing intrauterine growth restriction and preeclampsia in sickle cell pregnancy (PIPSICKLE): a randomised controlled trial (study protocol)". BMJ Open. 11 (8): e047949. doi:10.1136/bmjopen-2020-047949. PMC 8365818. PMID 34389570.
  47. ^ Akinajo, Opeyemi R.; Babah, Ochuwa A.; Banke-Thomas, Aduragbemi; Beňová, Lenka; Sam-Agudu, Nadia A.; Balogun, Mobolanle R.; Adaramoye, Victoria O.; Galadanci, Hadiza S.; Quao, Rachel A.; Afolabi, Bosede Bukola; Annerstedt, Kristi Sidney (February 13, 2024). "Acceptability of IV iron treatment for iron deficiency anaemia in pregnancy in Nigeria: a qualitative study with pregnant women, domestic decision-makers, and health care providers". Reproductive Health. 21 (1): 22. doi:10.1186/s12978-024-01743-y. ISSN 1742-4755. PMC 10863081. PMID 38347614.
  48. ^ a b Aworinde, Tobi (April 4, 2021). "UNILAG gynaecologist wins $2.5m Gates research grant". punchng.com. Retrieved December 8, 2021.
  49. ^ Okere, Alexander (July 18, 2020). "Mortality rate among pregnant women with sickle cell anaemia reducing — Expert". Punch Newspapers. Retrieved June 20, 2025.
  50. ^ "Professor Bosede Afolabi Awarded Prestigious International Research Grant". unilag.edu.ng. March 31, 2021. Retrieved December 8, 2021.
  51. ^ "Nigerian professor wins $2.5 million Bill Gates grant". Premium Times. Retrieved June 20, 2025.
  52. ^ "PIPSICKLE | About". PIPSICKLE trial. Retrieved June 20, 2025.
  53. ^ Afolabi, Bosede B. (June 16, 2023). "PIPSICKLE TRIAL: The journey so far". The Sickle Cell Bulletin. Retrieved June 20, 2025.
  54. ^ Adedinsewo, Demilade A.; Morales-Lara, Andrea Carolina; Afolabi, Bosede B.; Kushimo, Oyewole A.; Mbakwem, Amam C.; Ibiyemi, Kehinde F.; Ogunmodede, James Ayodele; Raji, Hadijat Olaide; Ringim, Sadiq H.; Habib, Abdullahi A.; Hamza, Sabiu M.; Ogah, Okechukwu S.; Obajimi, Gbolahan; Saanu, Olugbenga Oluseun (October 2024). "Artificial intelligence guided screening for cardiomyopathies in an obstetric population: a pragmatic randomized clinical trial". Nature Medicine. 30 (10): 2897–2906. doi:10.1038/s41591-024-03243-9. ISSN 1078-8956. PMC 11485252. PMID 39223284.